ClinicalTrials.gg

Autistic Disorder clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 1,034 studies for Autistic Disorder across more than 10 countries. 270 are recruiting or about to start. 876 of them are mainly about Autistic Disorder (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-17.

ClinicalTrials.gov finds 2,339 studies for Autistic Disorder. How that becomes 1,030 here

This page counts the studies the registry files under Autistic Disorder, and those it files under no condition that list Autistic Disorderthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 2,339Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −1,190List Autistic Disorder as a condition, but the registry did not file them under itMost often written as “Autism Spectrum Disorder” (981), “Autism Spectrum Disorder (ASD)” (79), and “Autism Spectrum Disorders” (76). The registry filed 9 of them under no condition at all, and the others under other conditions only, most often Autism Spectrum Disorder (1,165) and Attention Deficit Disorder with Hyperactivity (65).
  3. −124Match it another way73 name it in the title, 22 in a keyword, and 29 by a synonym or other text the search reads.
  4. 1,025Counted here and found by its search2 of them list Autistic Disorder in their own words; the registry filed them under no condition.
  5. +5
    Counted here, but its search does not find them
  6. 1,030The count on this page

Status

Completed
567
Recruiting
183
Status unknown
80
Not yet recruiting
68
Terminated
45
Active, not recruiting
43

Phase

Phase 2
161
Phase 1
68
Phase 3
66
Phase 4
23
Early Phase 1
7

Where

United States
603
France
50
Italy
44
United Kingdom
37
Canada
30
China
26

Who develops what

Add Autistic Disorder to watchlistPro · free during the betaEvery Monday by email · turn it off any time

Every program with a company-led study here in the last two years, whatever its size: 5 programs from 4 companies, 2 with this as their studies’ main aim; 4 with a live phase 3 study; 0 primary completions in the next 12 months.

Comparator & background therapies

What other companies’ phase 2+ studies give as the comparator or the background here (its leading trial sponsor and partners left out): a sign of what new drugs are measured against, not by itself the standard of care, its prescriptions or its market.

None given by two companies or more yet.

Programs

“Meets, by arms” reads each study’s arms: vs its arm against the therapy’s; + X vs a combination against it; added to it plus the therapy against the therapy; studied with given together only. The next primary completion is the next phase-3 study’s when there is one.

The 5 programs — sign in to see the whole list, free: filter by phase and aim, sort by late development, direct comparisons or the next primary completion.

Primary completion in the next 12 months (0)

Live phase 2 and 3 studies of these programs. Primary completion is when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced.

None in the next 12 months.

Read from ClinicalTrials.gov, industry-led studies. Main aim: this is the study’s judged main condition; named, not the main aim: the sponsor names it, the study is about something else; registry mapping only: only the registry’s mapping put it here. Leading trial sponsor is the company leading the most industry studies of a drug, a measure of trial activity, not of rights. US and EU rights, and Approved: from the regulators’ records (FDA’s Drugs@FDA via openFDA; EMA’s medicines data) — the holder of a marketed or authorized original, generics and other companies’ versions; not rights elsewhere, nor approval for this condition. Phase 4 trial recorded, where neither lists it: a phase 4 study exists somewhere. Not read yet: labels by indication, exclusivity, licenses, line of therapy, academic comparators, sales.

What is being tested here

Drugs under test in Autistic Disorder studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug classes tested here Antipsychotics 1 open · SSRIs 1 open · mTOR inhibitors 1 open · Stimulants 1 open · Anxiolytics 1 open

Coming up

74studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 183 Autistic Disorder studies recruiting now, 33 (18%) set no upper age limit and 143 (78%) stop at 75 or younger. 148 (81%) take children under 18. 1 (1%) are for women only and 2 (1%) for men only; 56 (31%) take healthy volunteers.

Recruiting studies that take each age, of 183
AgeWomenMen
1095 (52%)95 (52%)
1879 (43%)80 (44%)
3064 (35%)64 (35%)
4054 (30%)54 (30%)
5047 (26%)47 (26%)
6543 (23%)42 (23%)
7540 (22%)39 (21%)
8538 (21%)37 (20%)

Across all 1,034 studies, recruiting or not: 85% stop at 75 or younger and 84% at 65; 84% take children; 2% are for women only and 3% for men only; 28% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Autistic Disorder studies take

Of 44 phase 2 interventional studies under Autistic Disorder, half reached primary completion within 39 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 124 mo17–50 · 19 studies——
Phase 239 mo24–62 · 44 studies—46 mo24–63 · 35 studies
Phase 333 mo25–48 · 15 studies——
Interventional, no phase26 mo13–52 · 367 studies—26 mo14–52 · 355 studies
Observational43 mo20–120 · 65 studies—72 mo27–144 · 57 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 18, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 1,034. Browse all 1,034 → or search them.